Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

PVLA

Palvella Therapeutics Inc

140.31

Jul 06 • 04:00PM ET -6.45 (-4.39%)

Healthcare Biotechnology USA Mid NASD

Peers: KYMR MANE ORKA RYTM KRYS NUVL BMRN INCY AXSM NBIX

| Held by: XBI VTI IWM IWO VXF VTWO VHT VFMO LFSC SBIO

Scroll to Statements

Index	RUT
Market Cap	2.01B
Enterprise Value	1.77B
Income	-49.30M
Sales	0.00M
Book/sh	14.76
Cash/sh	18.26
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	29
IPO	Jan 02, 2015

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	9.51
P/C	7.69
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	5.20
Current Ratio	28.88
Debt/Eq	0.08
LT Debt/Eq	0.08
Option/Short	Yes / Yes

EPS (ttm)	-4.17
EPS next Y	-6.43
EPS next Q	-1.16
EPS this Y	-49.81%
EPS next Y	-15.73%
EPS next 5Y	12.81%
EPS past 3/5Y	53.08% 41.62%
Sales past 3/5Y	- -
EPS Y/Y TTM	66.94%
Sales Y/Y TTM	-
EPS Q/Q	-62.12%
Sales Q/Q	-
Earnings	May 07 BMO
EPS/Sales Surpr.	-28.34% -

Insider Own	29.40%
Insider Trans	-0.45%
Inst Own	83.76%
Inst Trans	33.22%
ROA	-28.73%
ROE	-34.25%
ROIC	-106.76%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	13.48%
SMA50	15.87%
SMA200	37.80%
Trades

Shs Outstand	15.74M
Shs Float	10.13M
Short Float	20.50%
Short Ratio	7.89
Short Interest	2.08M
52W High	161.38 -13.06%
52W Low	23.76 490.53%
Volatility	8.83% 7.31%
ATR (14)	9.45
RSI (14)	58.64
Beta	-0.17
Rel Volume	0.75
Avg Volume	263.10K
Volume	197,584

Perf Week	-5.33%
Perf Month	21.56%
Perf Quarter	13.65%
Perf Half Y	34.05%
Perf YTD	34.05%
Perf Year	481.72%
Perf 3Y	899.36%
Perf 5Y	-51.82%
Perf 10Y	6.30%
Recom	1.00
Target Price	229.00
Prev Close	146.76
Price	140.31
Change	-4.39%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)